Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiya Okuda

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Endothelial injury and CKD]Seiji Ueda, Yuriko Matsumoto, Yusuke Kaida, et al.
Current Drug Metabolism|March 12, 2009
Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disordersSho-ichi Yamagishi, Takanori Matsui, Seiji Ueda, et al.
Current Pharmaceutical Design|May 14, 2008
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathySho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, et al.
Plos One|March 4, 2014
Involvement of iron-evoked oxidative stress in smoking-related endothelial dysfunction in healthy young menKei Fukami, Sho-ichi Yamagishi, Shuji Iida, et al.
Clinical and Experimental Nephrology|June 27, 2007
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yuriko Matsumoto, et al.
Protein and Peptide Letters|March 11, 2010
Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury in vitroTakanori Matsui, Sho-ichi Yamagishi, Seiji Ueda, et al.
Current Pharmaceutical Design|November 11, 2008
Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complicationsSho-ichi Yamagishi, Seiji Ueda, Kazuo Nakamura, et al.
Clinical Kidney Journal|April 17, 2015
Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patientsKei Fukami, Sho-Ichi Yamagishi, Kazuko Sakai, et al.
The Journal of Laboratory and Clinical Medicine|July 19, 2005
Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in ratsToru Sanai, Nobuaki Oochi, Mitsuo Okada, et al.
Annals of Nuclear Medicine|August 16, 2005
Evaluation of exercise-induced acute renal failure in renal hypouricemia using Tc-99m DTPA renographyHidemi Nishida, Hayato Kaida, Masatoshi Ishibashi, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Endothelial injury and CKD]Seiji Ueda, Yuriko Matsumoto, Yusuke Kaida, et al.
Current Drug Metabolism|March 12, 2009
Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disordersSho-ichi Yamagishi, Takanori Matsui, Seiji Ueda, et al.
Current Pharmaceutical Design|May 14, 2008
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathySho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, et al.
Plos One|March 4, 2014
Involvement of iron-evoked oxidative stress in smoking-related endothelial dysfunction in healthy young menKei Fukami, Sho-ichi Yamagishi, Shuji Iida, et al.
Clinical and Experimental Nephrology|June 27, 2007
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yuriko Matsumoto, et al.
Protein and Peptide Letters|March 11, 2010
Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury in vitroTakanori Matsui, Sho-ichi Yamagishi, Seiji Ueda, et al.
Current Pharmaceutical Design|November 11, 2008
Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complicationsSho-ichi Yamagishi, Seiji Ueda, Kazuo Nakamura, et al.
Clinical Kidney Journal|April 17, 2015
Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patientsKei Fukami, Sho-Ichi Yamagishi, Kazuko Sakai, et al.
The Journal of Laboratory and Clinical Medicine|July 19, 2005
Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in ratsToru Sanai, Nobuaki Oochi, Mitsuo Okada, et al.
Annals of Nuclear Medicine|August 16, 2005
Evaluation of exercise-induced acute renal failure in renal hypouricemia using Tc-99m DTPA renographyHidemi Nishida, Hayato Kaida, Masatoshi Ishibashi, et al.
Pageof 12